IPSC-DERIVED NK CELLS MEDIATE ROBUST ANTI-TUMOR ACTIVITY AGAINST GLIOBLASTOMA

被引：1

作者：

Miller, Jeffrey ^{[1
]}

Cichocki, Frank ^{[1
]}

Ning, Jianfang ^{[1
]}

Bjordahl, Ryan ^{[2
]}

Davis, Zachary ^{[1
]}

Tuininga, Katie ^{[1
]}

Wang, Hongbo ^{[1
]}

Rogers, Paul ^{[2
]}

Ge, Moyar ^{[2
]}

Lee, Tom ^{[2
]}

Valamehr, Bob ^{[2
]}

Chen, Clark ^{[2
]}

机构：

[1] Univ Minnesota, Minneapolis, MN USA

[2] Fate Therapeut Inc, San Diego, CA USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷

关键词：

D O I：

10.1136/jitc-2020-SITC2020.0155

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

155

引用

页码：A93 / A94

页数：2

共 50 条

[21] REDIRECTING STROMAL CELLS TO IGNITE ANTI-TUMOR IMMUNITY AGAINST GLIOBLASTOMA
Devries, Anna
von Roemeling, Christina
Moor, Rachel
Wummer, Brandon
Weidert, Frances
Chardon-Robles, Jonathan
Ligon, John
Castillo, Paul
Mendez-Gomez, Hector
Sayour, Elias
NEURO-ONCOLOGY, 2024, 26
[22] TALEN®-BASED GENE EDITED IPSC-DERIVED NK (INK) CELLS DEMONSTRATE ENHANCED ANTITUMOR ACTIVITY
Chen, An-Ping
Gao, Peng
Ashok, Preeti
Ma, Marshall Chao
Zou, David
Chambers, Andrea
Lin, Liang
Chang, Hao-Ming
Arulanandam, Antonio
Eyquem, Justin
Burchi, Elisabetta
Rath, Armin
Frankel, Stanley
Boyne, Alex
Juillerat, Alexandre
Duchateau, Philippe
Teper, Daniel
Dilmac, Nejmi
Li, Wei
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A339 - A339
[23] synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy
Lupo K.B.
Yao X.
Borde S.
Wang J.
Torregrosa-Allen S.
Elzey B.D.
Utturkar S.
Lanman N.A.
McIntosh M.
Matosevic S.
Nature Communications, 15 (1)
[24] Notch Activation Rescues Exhaustion in CISH-Deleted Hum iPSC-Derived Natural Killer Cells to Promote In Vivo Persistence and Enhance Anti-Tumor Activity
Zhu, Huang
Blum, Robert
Wu, Zhengming
Bahena, Andres
Hoel, Hanna Julie
Ask, Eivind Heggernes
Guan, Kun-Liang
Malmberg, Karl-Johan
Kaufman, Dan S.
BLOOD, 2018, 132
[25] iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy
Cichocki, Frank
Bjordahl, Ryan
Gaidarova, Svetlana
Mahmood, Sajid
Abujarour, Ramzey
Wang, Hongbo
Tuininga, Katie
Felices, Martin
Davis, Zachary B.
Bendzick, Laura
Clarke, Raedun
Stokely, Laurel
Rogers, Paul
Ge, Moyar
Robinson, Megan
Rezner, Betsy
Robbins, David L.
Lee, Tom T.
Kaufman, Dan S.
Blazar, Bruce R.
Valamehr, Bahram
Miller, Jeffrey S.
SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (568)
[26] Anti-tumor activity of safranal against neuroblastoma cells
Samarghandian, Saeed
Shoshtari, Mohammad Ebrahim
Sargolzaei, Javad
Hossinimoghadam, Hosna
Farahzad, Jabbari Azad
PHARMACOGNOSY MAGAZINE, 2014, 10 (38) : 419 - 424
[27] CD19 CAR-expressing iPSC-derived NK cells effectively enhance migration and cytotoxicity into glioblastoma by targeting to the pericytes in tumor microenvironment
Kong, Dasom
Kwon, Daekee
Moon, Bokyung
Kim, Da-Hyun
Kim, Min-Ji
Choi, Jungju
Kang, Kyung-Sun
BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
[28] CD19 CAR-expressing iPSC-derived NK cells effectively enhance migration and cytotoxicity into glioblastoma by targeting to the pericytes in tumor microenvironment
Kong, Dasom
Kwon, Daekee
Moon, Bokyung
Kim, Da-Hyun
Kang, Kyung-Sun
CANCER RESEARCH, 2024, 84 (06)
[29] Combination of Three Unique Anti-Tumor Modalities Engineered into iPSC-Derived T Cells Demonstrate a Synergistic Effect in Overcoming Tumor Heterogeneity and Cancer Escape
Yang, Bi-Huei
Lin, Yu-Sheng Eason
Shirinbak, Soheila
Yeh, Wen-I
Pribadi, Mochtar
Chu, Hui-Yi
Gutierrez, Alma
Mehta, Amit
Avramis, Earl
Petrovic, Roseanna
Whitlock, Benjamin
ORourke, Jason
van der Stegen, Sjoukje
Lee, Tom
Witty, Alec
Peralta, Eigen
Hosking, Martin
Chang, Chia-Wei
Valamehr, Bahram
BLOOD, 2021, 138
[30] T Cell-dependent Anti-tumor Activity of NK Cells
Shanker, Anil
Uzhachenko, Roman V.
JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 759 - 759

← 1 2 3 4 5 →